SCHEMBL23971227

SCHEMBL23971227

CC(C)(C)OC(=O)c1ccnn1CCCCBr

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT1 P17948 8/20 0.35
▸ KDR P35968 8/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ F2 P00734 1/20 0.32
▸ PLAU P00749 1/20 0.32
▸ KLKB1 P03952 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA9 Q16790 1/20 0.31
▸ CA14 Q9ULX7 1/20 0.31
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23971010 0.99 FLT1 (0.34) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL23971229 0.99 FLT1 (0.34) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL13141164 0.82 FLT1 (0.37) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL17067436 0.77 FLT1 (0.34) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL29069810 0.75 L3MBTL1 (0.37) FLT1KDRNPC1RAB9AHTT
SCHEMBL30159053 0.75 SMN1; SMN2 (0.50) NPC1RAB9AHTTL3MBTL1GAA
SCHEMBL31646524 0.74 DRD2 (0.46) GAAKMT2ACA12CA1CA2
SCHEMBL24875516 0.74 F2 (0.44) FLT1KDRNPC1RAB9AMAPK1
SCHEMBL31518503 0.73 SMN1; SMN2 (0.44) NPC1MAPK1HTTGAASMN1; SMN2
SCHEMBL30861020 0.73 KDM4E (0.46) CA12CA1CA2CA9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976083-B2 Inhibitors of peptidylarginine deiminases GILEAD SCIENCES, INC. (US) 2024-05-07 — — US disclosed
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 — — CN disclosed
EP-4143189-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2023-03-08 — — EP disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 — — US disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 — — US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 — — CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 — — WO disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11976083-B2 Inhibitors of peptidylarginine deiminases PADI4, PADI2, PADI1 FLT1 1299/4885KDR 2510/4885NPC1 3253/4885
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 FLT1 1299/4885KDR 2510/4885NPC1 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback